
Assessment of circulating levels of microRNA-326, microRNA-424, and microRNA-511 as biomarkers for hepatocellular carcinoma in Egyptians
Author(s) -
Samar Samir Youssef,
Asmaa El fiky,
Mohamed Mahmoud Nabeel,
Hend Ibrahim Shousha,
Tamer Elbaz,
Dalia Omran,
Mohammad Saeed Marie,
Mohammad A Elzahry,
Amr Abul-Fotouh,
Ahmed I. Hashem,
Mohamed F Guda,
Ashraf Omar Abdelaziz
Publication year - 2022
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v14.i8.1562
Subject(s) - microrna , hepatocellular carcinoma , medicine , oncology , cancer , receiver operating characteristic , bioinformatics , pathology , cancer research , gene , biology , genetics
Hepatocellular carcinoma (HCC) is the fifth most common cancer. Differential expression of microRNAs (miRNAs)-326, miRNA-424, and miRNA-511 has been associated with the diagnosis and prognosis of HCC in different populations. However, limited information is available regarding their expression in Egyptian HCC patients.